These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16951768

  • 1. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
    Erkus M, Meteoglu I, Culhaci N, Meydan N, Erdogdu I.
    Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast.
    Engels K, Fox SB, Whitehouse RM, Gatter KC, Harris AL.
    J Pathol; 1997 Aug; 182(4):414-20. PubMed ID: 9306962
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.
    Kurosumi M, Sugamata N, Tabei T, Inoue K, Matsumoto H, Suemasu K, Higashi Y.
    Anticancer Res; 2002 Aug; 22(1A):331-8. PubMed ID: 12017313
    [Abstract] [Full Text] [Related]

  • 8. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S, Wang J, Bourne P, Yang Q, Tang P.
    Ann Clin Lab Sci; 2007 Aug; 37(2):127-34. PubMed ID: 17522367
    [Abstract] [Full Text] [Related]

  • 9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S, Lambein K, Huizing MT, Braems G, Asjoe FT, Hellemans H, Van Marck E, Weyler J, Praet M, Van den Broecke R, Vermorken JB, Tjalma WA.
    Breast J; 2009 Jan; 15(2):120-32. PubMed ID: 19292797
    [Abstract] [Full Text] [Related]

  • 11. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ.
    Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns.
    Adler EH, Sunkara JL, Patchefsky AS, Koss LG, Oktay MH.
    Hum Pathol; 2012 Apr; 43(4):550-6. PubMed ID: 21925705
    [Abstract] [Full Text] [Related]

  • 20. Correlation of p53 and cerbB2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast.
    Tan PH, Chuah KL, Chiang G, Wong CY, Dong F, Bay BH.
    Oncol Rep; 2002 Apr; 9(5):1081-6. PubMed ID: 12168077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.